NDC 13668-592

APREPITANT

Aprepitant

APREPITANT is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Aprepitant.

Product ID13668-592_56f2d9cd-4356-458b-94c3-198405d865e6
NDC13668-592
Product TypeHuman Prescription Drug
Proprietary NameAPREPITANT
Generic NameAprepitant
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-10-21
Marketing CategoryANDA / ANDA
Application NumberANDA211835
Labeler NameTorrent Pharmaceuticals Limited
Substance NameAPREPITANT
Active Ingredient Strength80 mg/1
Pharm ClassesCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 13668-592-84

1 BLISTER PACK in 1 CARTON (13668-592-84) > 2 CAPSULE in 1 BLISTER PACK (13668-592-85)
Marketing Start Date2020-10-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "APREPITANT" or generic name "Aprepitant"

NDCBrand NameGeneric Name
0781-2321Aprepitantaprepitant
0781-2322Aprepitantaprepitant
68462-112AprepitantAprepitant
68462-583AprepitantAprepitant
68462-584AprepitantAprepitant
68462-585AprepitantAprepitant
0781-2323AprepitantAprepitant
0781-4063AprepitantAprepitant
13668-594APREPITANTAPREPITANT
13668-591APREPITANTAPREPITANT
13668-592APREPITANTAPREPITANT
13668-593APREPITANTAPREPITANT
0006-0461EMENDaprepitant
0006-0462EMENDaprepitant
0006-0464EMENDaprepitant
0006-3066EMENDaprepitant
0006-3862EMENDaprepitant

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.